Trials / Completed
CompletedNCT01777503
The Elderly ACS II Trial
Phase IV: A Comparison of Reduced-dose Prasugrel and Clopidogrel in Elderly Patients With Acute Coronary Syndrome Undergoing Early Percutaneous Coronary Intervention (PCI)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 1,457 (actual)
- Sponsor
- Azienda USL Reggio Emilia - IRCCS · Other Government
- Sex
- All
- Age
- 75 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to compare reduced-dose prasugrel and standard dose clopidogrel in patients older than 74 years with ACS, including non-ST-elevation (NSTEACS) and ST-elevation (STEMI) patients, undergoing early PCI. The primary endpoint of the trial will be the one-year composite of (all-cause)death, myocardial infarction, stroke and re-hospitalization due to cardiovascular reasons or bleeding.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | prasugrel | prasugrel 5 mg o.d. |
| DRUG | Clopidogrel | 75 mg o.d. |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2017-01-25
- Completion
- 2017-12-19
- First posted
- 2013-01-29
- Last updated
- 2025-06-24
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT01777503. Inclusion in this directory is not an endorsement.